Innovation and Technology Adoption in Health Care Markets
| Author | : | |
| Rating | : | 4.73 (858 Votes) |
| Asin | : | 0844742686 |
| Format Type | : | paperback |
| Number of Pages | : | 120 Pages |
| Publish Date | : | 2015-02-12 |
| Language | : | English |
DESCRIPTION:
Harris Graduate School of Public Policy. Philipson is a visiting scholar at AEI and the Daniel Levin Professor at the University of Chicago's Irving B. Jena is a visiting fellow at the Bing Center for Health Economics at the RAND Corporation and a fellow in the Medical Scientist Training Program at the University of Chicago.Tomas J. . About the AuthorAnupam B
Groundbreaking! Ross Kessler I just finished reading this book and have to say it is a well written, insightful, and novel approach to asking the important question: Are health care systems paying for drugs in a way that slows the development of new, better drugs? Kudos to the author for having the guts to approach this controversal subject. Anyone who is involved in health care or health care technology should give this book a quick read!
Jena is a visiting fellow at the Bing Center for Health Economics at the RAND Corporation and a fellow in the Medical Scientist Training Program at the University of Chicago.Tomas J. Philipson is a visiting scholar at AEI and the Daniel Levin Professor at the University of Chicago's Irving B. Anupam B. . Harris Graduate School of Public Policy
Developers of drugs to treat HIV/AIDS, for example, earn lifetime profits equal to only 5 percent of the estimated $1.4 trillion social value of their treatments. Jena and Tomas J. Increasingly, these efforts have relied on "cost-effectiveness analysis" that balances costs against patient benefits to determine which treatments will qualify for reimbursement.Is the use of cost-effectiveness analysis to guide technology adoption wise? Although reimbursement criteria may satisfy government health budgets today, they threaten to stifle the innovation that will generate new breakthroughs in health c